Details for Patent: 9,238,657
✉ Email this page to a colleague
Which drugs does patent 9,238,657 protect, and when does it expire?
Patent 9,238,657 protects FETROJA and is included in one NDA.
This patent has forty-six patent family members in thirty-seven countries.
Summary for Patent: 9,238,657
| Title: | Cephalosporin having catechol group |
| Abstract: | The present disclosure describes Cephem compounds of the formula: ##STR00001## wherein, X is N, CH or C--Cl; T is S or the like; A and G are lower alkylene or the like; B is a single bond or the like; D is optionally present, and when present is, --NR.sup.7--, --CO--, --CO--NR.sup.7--, --NR.sup.7--CO--, --NR.sup.7--CO--NR.sup.7--, or the like; F is optionally present, and when present is or phenylene; R.sup.3 and R.sup.4 are --OR.sup.8; R.sup.5 and R.sup.6 each is independently hydrogen, halogen, nitrile, or --OR.sup.8; or an ester at the carboxyl at the 7-position side chain or at the 4-position, a compound protected at the amino on the ring in the 7-side chain, a pharmaceutically acceptable salt, or a solvate thereof, which have a wide antimicrobial spectrum and have potent antimicrobial activity against beta-lactamase producing Gram negative bacteria. |
| Inventor(s): | Nishitani; Yasuhiro (Osaka, JP), Yamawaki; Kenji (Osaka, JP), Takeoka; Yusuke (Sapporo, JP), Sugimoto; Hideki (Osaka, JP), Hisakawa; Shinya (Osaka, JP), Aoki; Toshiaki (Osaka, JP) |
| Assignee: | SHIONOGI & CO., LTD. (Osaka, JP) |
| Application Number: | 13/063,878 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 9,238,657
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING BACTERIAL INFECTIONS | ⤷ Try a Trial | ||
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING COMPLICATED URINARY TRACT INFECTIONS (CUTI), INCLUDING PYELONEPHRITIS, COMPRISING ADMINISTERING CEFIDEROCOL SULFATE TOSYLATE | ⤷ Try a Trial | ||
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA (HABP/VABP) COMPRISING ADMINISTERING CEFIDEROCOL SULFATE TOSYLATE | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,238,657
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2008-280828 | Oct 31, 2008 |
| PCT Information | |||
| PCT Filed | October 27, 2009 | PCT Application Number: | PCT/JP2009/068400 |
| PCT Publication Date: | May 06, 2010 | PCT Publication Number: | WO2010/050468 |
International Family Members for US Patent 9,238,657
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009310959 | ⤷ Try a Trial | |||
| Brazil | PI0921701 | ⤷ Try a Trial | |||
| Canada | 2736953 | ⤷ Try a Trial | |||
| Chile | 2011000939 | ⤷ Try a Trial | |||
| China | 102203100 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
